Recurrent Malignant Neoplasm

general

Cancer that has recurred (come back), usually after a period of time during which the cancer could not be detected. The cancer may come back to the same place as the original (primary) tumor or to another place in the body.

56

Centers

401

Active Trials

$6.6B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Recurrent Malignant Neoplasm(56)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
53.2
253.2
3
NCI Comprehensive
Active Research Program
53.2
4
NCI Comprehensive
Active Research Program
53.2
5
NCI Comprehensive
Active Research Program
53.2
6
NCI Comprehensive
Active Research Program
53.2
7
NCI Comprehensive
Active Research Program
53.2
8
NCI Comprehensive
Active Research Program
53.2
9
NCI Comprehensive
Active Research Program
53.2
1053.2
11
NCI Comprehensive
Active Research Program
53.2
12
NCI Comprehensive
Active Research Program
53.2
13
NCI Comprehensive
Active Research Program
53.2
14
NCI Comprehensive
Active Research Program
53.2
15
Active Research Program
53.2
16
NCI Comprehensive
Active Research Program
53.2
17
Active Research Program
53.2
18
NCI Clinical
Active Research Program
53.2
19
NCI Comprehensive
Active Research Program
53.2
20
Active Research Program
53.2
21
Active Research Program
53.2
22
NCI Comprehensive
Active Research Program
53.2
23
Active Research Program
53.2
24
Active Research Program
53.2
25
Active Research Program
53.2
26
Active Research Program
53.2
27
Active Research Program
53.2
28
Active Research Program
53.2
29
NCI Comprehensive
30.7
3030.7
31
32
NCI Comprehensive
33
NCI Comprehensive
34
NCI Comprehensive
35
NCI Comprehensive
36
37
NCI Comprehensive
38
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
39
40
41
NCI Comprehensive
42
NCI Clinical
43
44
Cedars-Sinai CancerLos Angeles, CA
45
NCI Comprehensive
46
47
48
NCI Comprehensive
49
50
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
51
52
53
54
55
56

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →